Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend]
SEC Accession No. 0001213900-20-010308
Filing Date
2020-04-28
Accepted
2020-04-28 17:27:55
Documents
6

Document Format Files

Seq Description Document Type Size
1 AMENDMENT NO. 3 TO FORM S-1 ea121069-s1a3_aditxtherape.htm S-1/A 1129654
2 CONSENT OF DBBMCKENNON ea121069-ex231_aditxtherape.htm EX-23.1 1886
3 GRAPHIC image_001.jpg GRAPHIC 6917
4 GRAPHIC image_002.jpg GRAPHIC 60022
5 GRAPHIC image_003.jpg GRAPHIC 94687
6 GRAPHIC image_004.jpg GRAPHIC 74524
  Complete submission text file 0001213900-20-010308.txt   1458344
Mailing Address 11161 ANDERSON STREET SUITE 105-10014 LOMA LINDA CA 92354
Business Address 11161 ANDERSON STREET SUITE 105-10014 LOMA LINDA CA 92354 909-488-0844
ADiTx Therapeutics, Inc. (Filer) CIK: 0001726711 (see all company filings)

EIN.: 823204328 | State of Incorp.: DE | Fiscal Year End: 1231
Type: S-1/A | Act: 33 | File No.: 333-235933 | Film No.: 20826310
SIC: 2834 Pharmaceutical Preparations